Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Friday, April 11, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Authors
Posts by admin
admin
1872 POSTS
6 COMMENTS
Latest Pharma-News
Moberg Pharma meets primary endpoint for MOB-015 (topical terbinafine) in a phase 3 study for the treatment of Onychomycosis
admin
-
December 10, 2019
0
Latest Pharma-News
U.S. FDA approved Fast Track designation for Equillium’s itolizumab (EQUALISE Phase 1b study )for the treatment of lupus nephritis
admin
-
December 10, 2019
0
Clinical Data Management
Important data points in Protocol for CRFs Creation (CDM Prospective):
admin
-
December 9, 2019
0
Clinical Data Management
Parts of a clinical trial protocol and Clinical Data Management (CDM) prospective to review
admin
-
December 9, 2019
0
Latest Pharma-News
Only treatment approved in the US for relapsed or refractory hairy cell leukemia Approved by FDA at ASH 2019
admin
-
December 9, 2019
0
Latest Pharma-News
Amgen’s AVSOLA™ received FDA approval for AVSOLA™ (infliximab-axxq), For The Same Indications As Remicade® (infliximab)for the treatment of Rheumatoid Arthritis, Crohn’s Disease, Ulcerative Colitis,...
admin
-
December 9, 2019
0
Latest Pharma-News
ViiV Healthcare submits New Drug Application to the US FDA for fostemsavir, an investigational, first-in-class attachment inhibitor for the treatment of HIV in adults
admin
-
December 9, 2019
0
Latest Pharma-News
FDA authorizes marketing of diagnostic test cobas vivoDx that uses novel technology to detect Methicillin-resistant Staphylococcus aureus (MRSA) bacteria
admin
-
December 9, 2019
0
Latest Pharma-News
First investigational drug therapy for liver disease non alcoholic steatohepatitis (NASH) awaiting FDA approval
admin
-
December 9, 2019
0
Latest Pharma-News
Data fron XOSPATA® in FLT3 Mutation-Positive Relapsed/Refractory Acute Myeloid Leukemia at the 2019 American Society of Hematology Annual Meeting
admin
-
December 9, 2019
0
Latest Pharma-News
First generics of Gilenya approved by FDA for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients
admin
-
December 6, 2019
0
Latest Pharma-News
U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Alecto’s investigational therapeutic AL001, for the treatment of patients with...
admin
-
December 6, 2019
0
1
...
149
150
151
...
156
Page 150 of 156
TOP AUTHORS
admin
1872 POSTS
6 COMMENTS
OIdMIHuOdiu
0 POSTS
0 COMMENTS
tintin
0 POSTS
0 COMMENTS
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025